Cover [Abstract] Document Information [Table] Document Information [Line Items] Document Type Document Period End Date Entity Registrant Name Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Title of 12(g) Security Title of 12(g) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Condensed Consolidated Balance Sheets Statement [Table] Statement [Line Items] Statement Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Accounts Receivable, Net, Current Accounts receivable (less allowance for credit losses of $342 and $370 as of March 31, 2021 and December 31, 2020, respectively; including $137 and $172 due from related parties as of March 31, 2021 and December 31, 2020, respectively) Accounts receivable Inventory, Net Inventory Total Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Restricted Cash, Noncurrent Restricted cash Restricted cash Property, Plant and Equipment, Net Property and equipment, net Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Goodwill Balance as of end of period Balance as of beginning of period Goodwill Operating Lease, Right-of-Use Asset Right-of-use assets Other Assets, Noncurrent Other non-current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable (including $6 and $14 to related parties as of March 31, 2021 and December 31, 2020, respectively) Accrued Employee Benefits, Current Accrued compensation and benefits Other Accrued Liabilities, Current Other accrued expenses (including $4 and $1,377 to related parties as of March 31, 2021 and December 31, 2020, respectively) Total accrued expenses Contract with Customer, Liability, Current Deferred revenue (including $76 and $90 with related parties as of March 31, 2021 and December 31, 2020, respectively) Long-term Debt, Current Maturities Current portion of long term debt Operating Lease, Liability, Current Short term lease liabilities Other Liabilities, Current Other current liabilities Liabilities, Current Total current liabilities Warrants and Rights Outstanding Preferred stock warrant liability Contract with Customer, Liability, Noncurrent Deferred revenue, net of current portion Operating Lease, Liability, Noncurrent Long term lease liabilities Other Liabilities, Noncurrent Other non-current liabilities Total other non-current liabilities Liabilities Total liabilities Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock, $0.001 par value: Authorized-120,000,000 shares as of March 31, 2021 and December 31, 2020; issued and outstanding - 36,294,928 and 31,796,544 shares as of March 31, 2021 and December 31, 2020, respectively Additional Paid in Capital, Common Stock Additional paid-in capital Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Accumulated other comprehensive income Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Allowance for Doubtful Accounts Receivable, Current Allowance for Doubtful Accounts Receivable, Ending Balance Allowance for Doubtful Accounts Receivable, Beginning Balance Accounts receivable, reserve for doubtful accounts Accounts Receivable, Related Parties, Current Accounts receivable, related parties Accounts Payable, Related Parties, Current Accounts payable, related parties Amount for other accrued liabilities payable to related parties, used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Other Accrued Liabilities, Related Parties, Current Other accrued expenses, related parties The carrying amount of consideration received or receivable from related parties as of the balance sheet date on potential earnings that were not recognized as revenue in conformity with GAAP, and which are expected to be recognized as such within one year or the normal operating cycle, if longer, including sales, license fees, and royalties, but excluding interest income. Deferred Revenue, Related Parties, Current Deferred revenue, current, related parties Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common stock, authorized shares Common Stock, Shares, Issued Common stock, shares issued Common Stock, Shares, Outstanding Common stock, shares outstanding Condensed Consolidated Statements of Operations Revenue from Contract with Customer, Excluding Assessed Tax Total revenue Revenue Cost of Revenue [Abstract] Costs of goods sold: Cost of Revenue Total costs of goods sold and services Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development (including related party activity of $8 and $0 for the three months ended March 31, 2021 and 2020, respectively) Selling, General and Administrative Expense Selling, general, and administrative (including related party activity of $14 and $0 for the three months ended March 31, 2021 and 2020, respectively) Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Interest Income (Expense), Net Interest income (expense), net Other Nonoperating Income (Expense) Other expense, net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before income taxes Income Tax Expense (Benefit) Income tax benefit Net Income (Loss) Attributable to Parent Net loss Net loss Income (Loss) from Continuing Operations, Per Basic and Diluted Share Net loss per share, basic and diluted Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted-average common shares outstanding, basic and diluted Revenue from Related Parties Related party revenue Related Parties Amount in Cost of Sales Cost of revenue, related party activity Amount included in research and development related to transactions with related parties incurred and recorded in the statement of operations for the period. Related party activity research and development expenses Related party activity in selling, general and administrative expenses Condensed Consolidated Statements of Comprehensive Loss Other Comprehensive Income (Loss), Net of Tax [Abstract] Other comprehensive loss: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Cumulative translation adjustment Current period accumulated other comprehensive loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Total other comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Condensed Consolidated Statements of Cash Flows Net Cash Provided by (Used in) Operating Activities [Abstract] Operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation, Amortization and Accretion, Net Depreciation and amortization expense Inventory Valuation Adjustment Amortization Inventory Valuation Adjustment Amortization Inventory step-up amortization Accounts Receivable, Credit Loss Expense (Reversal) Credit loss expense on accounts receivable Credit loss expense Amount of amortization expense attributable to right-of-use asset. Right-of-Use Asset, Amortization Reduction in the carrying amounts of right-of-use assets Share-based Compensation Stock-based compensation expense Paid-in-Kind Interest Non-cash interest expense Gain (Loss) on Disposition of Property Plant Equipment Loss on disposal of fixed assets Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Receivable Accounts receivable Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Inventories Inventory Increase (Decrease) in Other Noncurrent Assets Other non-current assets Increase (Decrease) in Accounts Payable, Trade Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued compensation and benefits, other accrued expenses and other current liabilities The increase (decrease) in payables for costs incurred to acquire contracts. Increase (Decrease) In Payables For Contract Acquisition Costs Contract acquisition costs The increase (decrease) during the reporting period in the aggregate amount of lease liabilities. Increase Decrease In Operating Lease Liabilities Operating lease liabilities Increase (Decrease) in Other Noncurrent Liabilities Other non-current liabilities Increase (Decrease) in Deferred Revenue Deferred revenue Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Investing activities Payments to Acquire Property, Plant, and Equipment Purchases of property and equipment The cash inflow from grants for asset purchase. Proceeds From Grant For Asset Purchase Proceeds from RADx grant on assets purchased Net Cash Provided by (Used in) Investing Activities Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Financing activities Proceeds from Stock Options Exercised Proceeds from stock options exercised Proceeds from Issuance of Common Stock Proceeds from sale of common stock, net of issuance costs Sale of common stock in at-the-market offering, net Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Proceeds from ESPP purchase Repayments of Notes Payable Payments on notes payable Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Net increase (decrease) in cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Effect of foreign currency exchange rate on cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, restricted cash, and cash equivalents at end of period Cash, restricted cash, and cash equivalents at beginning of period Total cash, cash equivalents, and restricted cash Supplemental Disclosures of Cash Flow Information Supplemental cash flow information Interest Paid, Net Cash paid for interest Capital Expenditures Incurred but Not yet Paid Purchases of property and equipment included in accounts payable Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect [Abstract] Reconciliation of cash, cash equivalents, and restricted cash: Condensed Consolidated Statements of Stockholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity Shares, Outstanding Ending Balance (in shares) Beginning balance (in shares) Amount of stock options and vesting restricted stock options exercised. Stock Issued During Period, Value, Stock Options and Vesting Restricted Stock Exercised Exercise of common stock option and warrants and vesting of restricted stock Number of stock options and vesting restricted stock exercised during the period. Stock Issued During Period, Shares, Stock Options and Vesting Restricted Stock Exercised Exercise of common stock option and warrants and vesting of restricted stock (in shares) Stock Issued During Period, Value, New Issues Sale of common stock Stock Issued During Period, Shares, New Issues Sale of common stock (in shares) Stock Issued During Period, Shares, New Issues Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Stock-based compensation expense Stock Issued During Period, Value, Employee Stock Purchase Plan Employee stock purchase plan Stock Issued During Period, Shares, Employee Stock Purchase Plans Employee stock purchase plan (in shares) Organization and operations Nature of Operations [Text Block] Organization and operations Significant accounting policies Significant Accounting Policies [Text Block] Significant accounting policies Revenue recognition Revenue from Contract with Customer [Text Block] Revenue recognition Net loss per share Earnings Per Share [Text Block] Net loss per share Fair value of financial instruments Fair Value Disclosures [Text Block] Fair value of financial instruments Inventory Inventory Disclosure [Text Block] Inventory Allowance for Credit Loss Allowance for Credit Losses [Text Block] Allowance for Credit Loss Other accrued expenses and other non-current liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Other accrued expenses Warrants, stock-based compensation, stock options, restricted stock and restricted stock units Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Warrants, stock-based compensation, stock options, restricted stock and restricted stock units Leases Lessee, Operating Leases [Text Block] Leases Commitments and contingencies Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items] Commitments and contingencies Collaboration and license arrangements Commitments Disclosure [Text Block] Commitments and contingencies Notes payable Debt Disclosure [Text Block] Notes payable No definition available. Collaboration and license arrangements Collaborative Arrangement Disclosure [Text Block] Collaboration and license arrangements Employee benefit plans Pension and Other Postretirement Benefits Disclosure [Text Block] Employee benefit plans Goodwill and Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Goodwill and Intangible Assets Related party transactions Related Party Transactions Disclosure [Text Block] Related party transactions Accumulated other comprehensive income (loss) Other Comprehensive Income, Noncontrolling Interest [Text Block] Accumulated other comprehensive income (loss) Subsequent events Subsequent Events [Text Block] Subsequent events Consolidation, Policy [Policy Text Block] Principles of consolidation Use of Estimates, Policy [Policy Text Block] Use of estimates Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign Currency Income Tax, Policy [Policy Text Block] Income taxes Business Combinations Policy [Policy Text Block] Business combinations Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted Cash New Accounting Pronouncements, Policy [Policy Text Block] Recent accounting pronouncements Disaggregation of Revenue [Table Text Block] Schedule of disaggregated revenue Tabular disclosure of changes in deferred revenue from contracts with customers. Schedule of Changes in Deferred Revenue from Contracts with Customers [Table Text Block] Schedule of changes in deferred revenue from contracts with customers Capitalized Contract Cost [Table Text Block] Schedule of costs to obtain a contract Tabular disclosure of grant revenue activity. Schedule of Grant Revenue Activity [Table Text Block] Schedule of summary of the activity under WP2 Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of outstanding potentially dilutive securities that have been excluded in the calculation of diluted net loss per share Fair Value, by Balance Sheet Grouping [Table Text Block] Schedule of fair value measurements Schedule of Inventory, Current [Table Text Block] Summary of inventory Accounts Receivable, Allowance for Credit Loss [Table Text Block] Schedule of the allowance for credit losses Schedule of Accrued Liabilities [Table Text Block] Summary of other accrued expenses Other Noncurrent Liabilities [Table Text Block] Summary of other non-current liabilities Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block] Summary of share-based compensation expense for all stock awards Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of stock option activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Summary of restricted stock units activity Lease, Cost [Table Text Block] Summary of the lease costs recognized under ASC 842 Schedule of Maturities of Long-term Debt [Table Text Block] Schedule of debt payment obligations due based on principal payments Schedule of Goodwill [Table Text Block] Rollforward of goodwill balance Schedule of Finite-Lived Intangible Assets [Table Text Block] Summary of intangible assets Finite-lived Intangible Assets Amortization Expense [Table Text Block] Schedule of future estimated amortization expense of acquired intangible assets Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Stock by Class [Table] Class of Stock [Line Items] Initial Public Offering Gross Proceeds From Issuance Of Common Stock Gross Proceeds From Issuance Of Common Stock Gross proceeds Payments of Stock Issuance Costs Stock issuance cost Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Revenue recognition Period of payment from customers from the date of shipment or satisfaction of performance obligation with no discounts for early payment. Period of Payment from Customers Period of payment Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Transaction Price Allocated to Future Performance Obligations Revenue, Remaining Performance Obligation Amount of transaction price allocated to performance obligations Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Change in Contract with Customer, Liability [Abstract] Changes in deferred revenue from contracts with customers Contract with Customer, Liability Balance at end of period Balance at beginning of period Amount of deferral of revenue from transfer of good or service to customer. Contract with Customer, Liability, Deferral of Revenue Deferral of revenue Contract with Customer, Liability, Revenue Recognized Recognition of deferred revenue Capitalized Contract Cost [Abstract] Change in the balance of costs to obtain a contract Capitalized Contract Cost, Net Balance at end of period Balance at beginning of period Decrease in capitalized contract costs due to deferral of costs to obtain a contract. Capitalized Contract Cost, Deferral of Costs to Obtain a Contract Deferral of costs to obtain a contract Addition of capitalized contract costs due to recognition of costs to obtain a contract. Capitalized Contract Cost, Recognition of Costs to Obtain a Contract Recognition of costs to obtain a contract Revenue, Practical Expedient, Financing Component [true false] Revenue, Remaining Performance Obligation, Optional Exemption, Performance Obligation [true false] The amount of contract value. Contract Value Contract value Total WP2 grant amount Amount of grant proceeds used for assets. Procceds Used For Assets Total proceeds used for assets Amount of deferred proceeds for assets from grant. Deferred Proceeds For Assets Total deferred proceeds for assets Amount of deferred grant revenue recognized during the period. Deferred Grant Revenue Total deferred grant revenue Amount of grant recognized during the period. Grant Revenue Recognized Total recognized Grants Receivable Total amount accrued Amount of cash inflow for proceeds from grants. Proceeds From Grants Total cash received Total proceeds received Amount of proceeds from grants reasonably assured. Proceeds From Grants, Assured Total proceeds reasonably assured Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Net loss per share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of dilutive securities excluded in the calculation of diluted net loss per share The number of shares the entity is obligated to issue warrants for as of the reporting date. Obligation To Issue Warrants, In Shares Obligation to issue warrants, in shares Fair Value, by Balance Sheet Grouping [Table] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair value of financial instruments Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract] Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Assets, Fair Value Disclosure Total Inventory, Raw Materials, Gross Raw Materials Inventory, Work in Process, Gross Work in process Inventory, Finished Goods, Gross Finished goods Accounts Receivable, Allowance for Credit Loss, Writeoff Write-offs charged against allowances Carrying value as of the balance sheet date of obligations incurred through that date and payable for inventory. Accrued Inventory Accrued inventory purchases Carrying value as of the balance sheet date of obligations incurred through that date and payable for property and equipment purchases. Accrued Property and Equipment Purchase Accrued property and equipment purchases Accrued Royalties, Current Accrued royalties Accrued Professional Fees, Current Accrued professional services Carrying value as of the balance sheet date of obligations incurred and payable for research and development, design and engineering of products and services. Accrued Development Costs Accrued development costs Carrying value as of the balance sheet date of obligations incurred through that date and payable for accrued other cost. Accrued Other Cost Accrued other Other non-current liabilities Deferred Income Tax Liabilities, Net Deferred tax liabilities Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Warrants, stock-based compensation, stock options, restricted stock and restricted stock units Warrants And Rights, Exercised. Warrants And Rights, Exercised Number of shares (or other type of equity) issued during the period as a result of exercise of common stock warrants. Stock Issued During Period, Shares, Exercise Of Common Stock Warrants Exercise of common stock warrants (in shares) Allocated Share-based Compensation Expense Share-based compensation expense Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding at the end of the period (in shares) Outstanding at the beginning of the period (in shares) Options outstanding (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares authorized under the plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Additional shares authorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Shares available for grant under the plan (in shares) Period of options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition Share-based Compensation Arrangement by Share-based Payment Award, Award Option Period Option periods The annual increase in the number of shares available for issuance under the plan, represented as a percentage. Share Based Compensation Arrangement By Share Based Payment Award, Evergreen Provision, Annual Increase, Percentage Annual increase in the shares available for grant under the plan (as a percent of shares of common stock outstanding) The increase in number of shares available for issuance under the plan, as a result of evergreen provision. Share Based Compensation Arrangement By Share Based Payment Award, Evergreen Provision, Number Of Shares Increased Increase in the shares available for grant under the plan (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Vesting period (in years) Vesting period 1 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Vesting percentage 1 (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Options expiration period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Number outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Cancelled or forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Vested and expected to vest at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable at the end of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted-average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding at the end of the period (in dollars per share) Outstanding at the beginning of the period (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Cancelled or forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Vested and expected to vest at the end of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable at the end of the period (in dollars per share) No definition available. Share Based Compensation Arrangement By Share Based Payment Award Options Weighted Average Remaining Contractual Term [Abstract] Remaining contractual life Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Vested and expected to vest at the end of the period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable at the end of the period (in years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Aggregate intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Outstanding at the end of the period Outstanding at the beginning of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Intrinsic value of stock options exercised Exercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Vested and expected to vest at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Exercisable at the end of the period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted-average fair value of options granted Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition Period of recognition of unrecognized compensation cost Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted (in shares) Period for tranche 2 which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format. Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Period 2 Vesting period 2 Percentage of vesting of share-based compensation awards, tranche 2. Share-Based Compensation Arrangement By Share-Based Payment Award, Award Vesting Rights Percentage, Duration, Tranche 2 Vesting percentage 2 (as a percent) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Number of restricted stock units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Unvested restricted common stock at the end of the period (in shares) Unvested restricted common stock at the beginning of the period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Cancelled (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted-average grant date fair value per share Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Unvested restricted common stock at the end of the period (in dollars per share) Unvested restricted common stock at the beginning of the period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Cancelled (in dollars per share) Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Share-based Awards Other than Options Total unrecognized compensation cost related to unvested stock awards Lease, Cost [Abstract] Lease Costs Operating Lease, Cost Operating lease costs Lease, Cost Total lease cost Operating Lease, Payments Operating cash flows used for operating leases Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate No definition available. License Agreements [Abstract] License agreements Royalty Expense Royalty expense Period during which the company is to purchase minimum number of commercial units, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Minimum Number Of Commercial Units, Purchase, Period Period to purchase minimum number of commercial units The number of supply warrants to be issued upon termination of agreement and the purchase commitment is not met. Termination Of Agreement, Supply Warrants To Be Issued, Number Issuance of supply warrants on termination of agreement, number (in shares) The value per share of supply warrants to be issued upon termination of agreement and the purchase commitment is not met. Termination Of Agreement, Supply Warrants To Be Issued, Value Per Share Issuance of supply warrants on termination of agreement, value per share (in dollars per share) Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Long Term Debt Line of Credit Facility, Remaining Borrowing Capacity Additional amounts available to borrow Debt Instrument, Basis Spread on Variable Rate Margin on variable interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Interest rate (as a percent) Amortization of Debt Issuance Costs and Discounts Non-cash interest expense Debt payment obligations due based on principal payments Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2021 Long-term Debt Debt payment obligations Number of days notice to be given to terminate the agreement. Number of Days Notice to Terminate Agreement Number of days notice to terminate agreement Deferred Revenue Deferred revenue Represents the initial license fee receivable under collaboration and license arrangements. Collaboration And License Arrangements, Initial License Fee Receivable Initial license fee receivable Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Defined Contribution Plan, Cost Contribution made to the 401 (k) Plan Schedule of Goodwill [Table] Goodwill [Line Items] Rollforward of goodwill balance Goodwill, Translation and Purchase Accounting Adjustments Cumulative translation adjustment Finite-Lived Intangible Assets, Net [Abstract] Purchased intangible assets Finite-Lived Intangible Asset, Useful Life Estimated Useful Life Finite-Lived Intangible Assets, Gross Gross Carrying Value Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Amount of Cumulative translation adjustment for intangible assets acquired. Cumulative Translations Adjustments, Finite lived Intangible Assets Acquired Cumulative Translation Adjustment Finite-Lived Intangible Assets, Net Net Carrying Value Finite-Lived Intangible Assets, Remaining Amortization Period Weighted average life remaining Amortization of Intangible Assets Amortization expense Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Estimated amortization expense Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year Current year (2021) Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2025 Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized after the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date. Finite Lived Intangible Assets Amortization Expense After Year Four Thereafter Finite Lived Intangible Assets Net Including Cumulative Translation Adjustments Finite Lived Intangible Assets Net Including Cumulative Translation Adjustments Estimated Amortization Expenses No definition available. Underwritten public offerings Schedule of Subsidiary or Equity Method Investee [Table] Subsidiary or Equity Method Investee [Line Items] Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction Related party transactions Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Ending Balance Beginning balance Product and Service [Axis] Products And Services [Domain] Products and Services [Domain] Product [Member] Product revenue Service Other [Member] Service and other revenue License And Service [Member] Collaboration and license revenue Grant [Member] Grant revenue Sale of Stock [Axis] Sale Of Stock Name Of Transaction [Domain] Sale of Stock [Domain] Represents information relating to Underwritten public offering . Underwritten Public Offering [Member] Underwritten public offering Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common stock Additional Paid In Capital [Member] Additional paid-in capital Accumulated Other Comprehensive Income [Member] Accumulated other comprehensive income (loss) [Member] Retained Earnings [Member] Accumulated deficit Statistical Measurement [Axis] Range [Member] Range [Domain] Minimum [Member] Minimum Maximum [Member] Maximum This member stands for revenue relating to instrument products. Instrument Products [Member] Instruments This member stands for revenue relating to consumable and other products. Consumable And Other Products [Member] Consumable and other products Represents the information pertaining to service-type warranties. Service Type Warranties [Member] Service-type warranties Represents the information pertaining to research services. Research Services [Member] Research services This member stands for revenue relating to other services. Other Services [Member] Other services Geographical [Axis] Segment Geographical [Domain] Geographical [Domain] North America [Member] NA E M E A [Member] EMEA Asia Pacific [Member] Asia Pacific Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Represents the information pertaining to undelivered services related to initial and extended service-type warranties and research services. Undelivered Services Related To Initial And Extended Service Type Warranties And Research Services [Member] Service-type warranties and research services Represents the information pertaining to undelivered licenses of intellectual property. Undelivered Licenses Of Intellectual Property [Member] Undelivered licenses of intellectual property Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Arrangements And Nonarrangement Transactions [Member] Arrangements and Non-arrangement Transactions [Domain] Represents about Rapid Acceleration of Diagnostics (RADx) program workplan two. Rapid Acceleration Of Diagnostics Radx Program Workplan Two [Member] RADx WP2 Antidilutive Securities [Axis] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Information pertaining to unvested restricted common stock and restricted stock units. Unvested Restricted Common Stock And Restricted Stock Units [Member] Unvested restricted common stock and restricted stock units Employee Stock Option [Member] Outstanding stock options Warrant [Member] Warrants Class of Stock [Axis] Class Of Stock [Domain] Class of Stock [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value Inputs Level1 [Member] Level 1 Award Type [Axis] Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Award Type [Domain] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] This member stands for cost of product revenue. Cost Of Product Revenue [Member] Cost of product revenue This member stands for cost of service and other revenue. Cost Of Service And Other Revenue [Member] Cost of service and other revenue Research And Development Expense [Member] Research and development General And Administrative Expense [Member] General and administrative Plan Name [Axis] Plan Name [Domain] Plan Name [Domain] This member stands for 2007 stock based awards plan. Stock Based Awards2007 Plan [Member] 2007 Plan This member stands for the2017 Employee, Director and Consultant Equity Incentive Plan (the 2017 Plan). Employee Director And Consultant2017 Equity Incentive Plan [Member] 2017 Plan This member stands for Employee Stock Purchase Plan (the 2017 ESPP). Employee Stock Purchase2017 Plan [Member] 2017 ESPP Vesting [Axis] Vesting [Domain] Vesting [Domain] Share Based Compensation Award Tranche One [Member] Subject to a four year vesting schedule with 25% vesting on the first anniversary and the remaining vesting ratably on a monthly basis over the remaining three years Share Based Compensation Award Tranche Two [Member] Remaining 75% vesting ratably on a monthly basis over the remaining three years Restricted Stock [Member] Restricted stock Title of Individual [Axis] Title Of Individual With Relationship To Entity [Domain] Title of Individual [Domain] Executive Officer [Member] Executive Restricted Stock Units R S U [Member] Restricted stock units Share-based compensation awards, tranche seven. Share Based Compensation Award Tranche Seven [Member] Vested on May 31, 2020 Share-based compensation awards, tranche thirteen. Share Based Compensation Awards Tranche Thirteen [Member] Vest on December 31, 2021 This member stands for license agreements. License Agreements [Member] License agreements Related Party [Axis] Related Party [Domain] Related Party [Domain] This member stands for tufts university. Tufts University [Member] Tufts Debt Instrument [Axis] Debt Instrument Name [Domain] Debt Instrument, Name [Domain] This member stands for loan agreement. Loan Agreement [Member] Loan agreement Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Prime Rate [Member] Prime rate This member stands for Joint development and license agreement (JDLA). Joint Development And License Agreement [Member] Joint development and license agreement Represents information pertaining to Abbot license agreement. Abbot License Agreement [Member] Abbot license agreement Finite-Lived Intangible Assets by Major Class [Axis] Finite Lived Intangible Assets Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Developed Technology Rights [Member] Developed technology Customer Relationships [Member] Customer relationships Trade Names [Member] Trade names relating to know how finite-lived intangible assets. Know How [Member] Know How Noncompete Agreements [Member] Noncompete Agreements The member that stands for Harvard university. Harvard University [Member] Harvard University License Agreement Terms [Member] License Agreement Accumulated Translation Adjustment [Member] Cumulative Translation Adjustment